SUPN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,048,693.06

Supernus Pharmaceuticals Insider Trading History Chart

Supernus Pharmaceuticals Share Price & Price History

^$32.16

▲ +0.9 (2.88%)

As of 03/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Supernus Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/21/2025	Jonathan Rubin	SVP	Sell	927	$39.15	$36,292.05	7,853
2/4/2025	Padmanabh P. Bhatt	VP	Sell	9,477	$39.70	$376,236.90	10,149
1/28/2025	Padmanabh P. Bhatt	VP	Sell	700	$39.62	$27,734.00	10,149
11/7/2024	Frank Mottola	SVP	Sell	15,000	$36.98	$554,700.00	8,200
11/7/2024	Georges Gemayel	Director	Sell	14,213	$36.62	$520,480.06	13,315
11/7/2024	Jack A. Khattar	CEO	Sell	125,000	$36.68	$4,585,000.00	926,172
3/21/2024	Padmanabh P. Bhatt	VP	Sell	14,491	$35.31	$511,677.21	8,570
3/19/2024	Padmanabh P. Bhatt	VP	Sell	12,364	$35.31	$436,572.84	8,570
3/12/2024	Padmanabh P. Bhatt	VP	Sell	3,884	$32.99	$128,133.16	8,570
2/26/2024	Padmanabh P. Bhatt	VP	Sell	5,000	$30.21	$151,050.00	8,570
1/10/2024	Tami Tillotson Martin	VP	Sell	8,000	$27.91	$223,280.00	85,664
11/15/2023	Frederick M. Hudson	Director	Sell	9,093	$28.50	$259,150.50	33,231
11/14/2023	Frank Mottola	SVP	Sell	1,110	$28.13	$31,224.30	5,681
8/30/2023	Tami Tillotson Martin	VP	Sell	8,100	$32.00	$259,200.00	85,249
8/25/2023	Tami Tillotson Martin	VP	Sell	5,135	$31.59	$162,214.65	85,249
3/14/2023	Frank Mottola	SVP	Sell	4,780	$35.99	$172,032.20	4,737
2/2/2023	Jack A. Khattar	CEO	Sell	13,532	$42.05	$569,020.60	804,142
1/31/2023	Jack A. Khattar	CEO	Sell	976	$42.01	$41,001.76	794,961
1/17/2023	Jack A. Khattar	CEO	Sell	25,446	$40.03	$1,018,603.38	791,173
1/17/2023	Padmanabh P. Bhatt	VP	Sell	4,826	$39.92	$192,653.92	1,644
1/6/2023	Padmanabh P. Bhatt	VP	Sell	174	$39.90	$6,942.60	1,644
12/21/2022	Jack A. Khattar	CEO	Sell	11,354	$38.14	$433,041.56	814,699
12/1/2022	Padmanabh P. Bhatt	VP	Sell	5,000	$37.48	$187,400.00	1,644
11/25/2022	Jack A. Khattar	CEO	Sell	11,135	$35.18	$391,729.30	789,434
11/23/2022	Jack A. Khattar	CEO	Sell	2,259	$35.05	$79,177.95	782,775
11/21/2022	Jack A. Khattar	CEO	Sell	531	$35.01	$18,590.31	781,059
11/15/2022	Jack A. Khattar	CEO	Sell	1,115	$35.00	$39,025.00	780,742
11/11/2022	Padmanabh P. Bhatt	VP	Sell	6,800	$34.95	$237,660.00	1,644
11/9/2022	Padmanabh P. Bhatt	VP	Sell	700	$34.97	$24,479.00	1,644
8/22/2022	Tami Tillotson Martin	VP	Sell	5,000	$35.98	$179,900.00	87,220
8/15/2022	Jack A. Khattar	CEO	Sell	17,302	$34.03	$588,787.06	759,901
8/9/2022	Jack A. Khattar	CEO	Sell	39,431	$31.15	$1,228,275.65	724,978
8/4/2022	Tami Tillotson Martin	VP	Sell	5,000	$32.98	$164,900.00	87,220

See Full Table

SEC Filings (Institutional Ownership Changes) for Supernus Pharmaceuticals (NASDAQ:SUPN)

Institutional Buying and Selling by Quarter

Supernus Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/5/2025	Phocas Financial Corp.	108,479	$3.92M	0.5%	-0.9%	0.194%
2/27/2025	Jefferies Financial Group Inc.	24,600	$0.89M	0.0%	N/A	0.045%
2/19/2025	GF Fund Management CO. LTD.	1,159	$42K	0.0%	N/A	0.002%
2/18/2025	Ashford Capital Management Inc.	545,775	$19.74M	2.3%	+0.3%	0.988%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	100,020	$3.62M	0.0%	+24.7%	0.181%
2/17/2025	Voloridge Investment Management LLC	20,497	$0.74M	0.0%	-85.1%	0.037%
2/17/2025	Woodline Partners LP	423,828	$15.33M	0.1%	+124.8%	0.768%
2/17/2025	Vident Advisory LLC	14,392	$0.52M	0.0%	+2.2%	0.026%
2/17/2025	Squarepoint Ops LLC	20,492	$0.74M	0.0%	-2.3%	0.037%
2/17/2025	Two Sigma Advisers LP	7,800	$0.28M	0.0%	+14.7%	0.014%
2/17/2025	Two Sigma Investments LP	24,987	$0.90M	0.0%	-70.5%	0.045%
2/17/2025	Teza Capital Management LLC	6,622	$0.24M	0.0%	-25.6%	0.012%
2/17/2025	Systematic Financial Management LP	113,500	$4.10M	0.1%	+302.7%	0.206%
2/17/2025	Raiffeisen Bank International AG	671	$25K	0.0%	N/A	0.001%
2/17/2025	Point72 Asset Management L.P.	26,828	$0.97M	0.0%	N/A	0.049%
2/17/2025	Polar Capital Holdings Plc	1,687,930	$61.04M	0.3%	-12.9%	3.057%
2/17/2025	ProShare Advisors LLC	17,839	$0.65M	0.0%	+29.0%	0.032%
2/17/2025	Quantinno Capital Management LP	8,401	$0.30M	0.0%	+11.5%	0.015%
2/17/2025	Man Group plc	23,564	$0.85M	0.0%	-3.1%	0.043%
2/17/2025	Nuveen Asset Management LLC	134,127	$4.85M	0.0%	+0.7%	0.243%
2/17/2025	Millennium Management LLC	30,470	$1.10M	0.0%	-87.9%	0.055%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	28,563	$1.03M	0.0%	+3.9%	0.052%
2/17/2025	Jefferies Financial Group Inc.	24,600	$0.89M	0.0%	N/A	0.045%
2/17/2025	Gotham Asset Management LLC	39,212	$1.42M	0.0%	+3.8%	0.071%
2/17/2025	Graham Capital Management L.P.	6,908	$0.25M	0.0%	N/A	0.013%
2/17/2025	Deutsche Bank AG	105,583	$3.82M	0.0%	+226.2%	0.191%
2/17/2025	D. E. Shaw & Co. Inc.	545,658	$19.73M	0.0%	+33.5%	0.988%
2/17/2025	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	38,885	$1.41M	0.0%	-72.7%	0.070%
2/17/2025	Cubist Systematic Strategies LLC	139,522	$5.05M	0.0%	+944.2%	0.253%
2/17/2025	Centiva Capital LP	9,151	$0.33M	0.0%	N/A	0.017%
2/17/2025	BOKF NA	14,546	$0.55M	0.0%	-16.8%	0.026%
2/17/2025	Brevan Howard Capital Management LP	7,521	$0.27M	0.0%	N/A	0.014%
2/17/2025	Captrust Financial Advisors	17,394	$0.63M	0.0%	+84.6%	0.031%
2/17/2025	Bank of America Corp DE	373,088	$13.49M	0.0%	-0.6%	0.676%
2/17/2025	BNP Paribas Financial Markets	292,629	$10.58M	0.0%	+248.0%	0.530%
2/17/2025	Ameriprise Financial Inc.	450,261	$16.28M	0.0%	-17.5%	0.815%
2/17/2025	Aristotle Capital Boston LLC	1,075,868	$38.90M	1.4%	-9.9%	1.948%
2/14/2025	Mercer Global Advisors Inc. ADV	10,179	$0.37M	0.0%	-8.3%	0.018%
2/14/2025	Comerica Bank	37,548	$1.36M	0.0%	+71.0%	0.068%
2/14/2025	PDT Partners LLC	55,008	$1.99M	0.2%	+48.2%	0.100%
2/14/2025	Schonfeld Strategic Advisors LLC	10,730	$0.39M	0.0%	N/A	0.019%
2/14/2025	Northern Trust Corp	717,161	$25.93M	0.0%	+18.3%	1.299%
2/14/2025	The Manufacturers Life Insurance Company	25,241	$0.91M	0.0%	-3.1%	0.046%
2/14/2025	Aquatic Capital Management LLC	826	$30K	0.0%	-70.5%	0.001%
2/14/2025	Voya Investment Management LLC	42,808	$1.55M	0.0%	-3.4%	0.078%
2/14/2025	Price T Rowe Associates Inc. MD	40,428	$1.46M	0.0%	-14.7%	0.073%
2/14/2025	Eversept Partners LP	105,581	$3.82M	0.3%	N/A	0.191%
2/14/2025	Hsbc Holdings PLC	228,030	$8.25M	0.0%	-8.9%	0.413%
2/14/2025	Stifel Financial Corp	67,963	$2.46M	0.0%	-1.7%	0.123%
2/14/2025	State of Tennessee Department of Treasury	13,289	$0.48M	0.0%	-27.6%	0.024%
2/14/2025	Tower Research Capital LLC TRC	3,163	$0.11M	0.0%	+39.1%	0.006%
2/14/2025	MetLife Investment Management LLC	30,822	$1.12M	0.0%	+4.7%	0.056%
2/14/2025	First Trust Advisors LP	27,019	$0.98M	0.0%	-48.1%	0.049%
2/14/2025	Dimensional Fund Advisors LP	2,878,545	$104.09M	0.0%	-0.1%	5.213%
2/14/2025	Epoch Investment Partners Inc.	85,691	$3.10M	0.0%	+59.5%	0.155%
2/14/2025	Alpha DNA Investment Management LLC	12,218	$0.44M	0.2%	N/A	0.022%
2/13/2025	CANADA LIFE ASSURANCE Co	64,940	$2.35M	0.0%	-7.0%	0.118%
2/13/2025	Canada Pension Plan Investment Board	2,700	$98K	0.0%	-95.6%	0.005%
2/13/2025	Keeley Teton Advisors LLC	13,637	$0.49M	0.1%	-13.7%	0.025%
2/13/2025	XTX Topco Ltd	7,822	$0.28M	0.0%	-20.6%	0.014%
2/13/2025	Barclays PLC	122,849	$4.44M	0.0%	+12.9%	0.222%
2/13/2025	Summit Investment Advisors Inc.	5,253	$0.19M	0.2%	+7.6%	0.010%
2/13/2025	Sterling Capital Management LLC	14,562	$0.53M	0.0%	+8,619.8%	0.026%
2/13/2025	Raymond James Financial Inc.	189,364	$6.85M	0.0%	N/A	0.343%
2/13/2025	Martingale Asset Management L P	44,592	$1.61M	0.0%	+18.0%	0.081%
2/13/2025	Capula Management Ltd	8,574	$0.31M	0.0%	N/A	0.016%
2/13/2025	Renaissance Technologies LLC	1,598,722	$57.81M	0.1%	-7.5%	2.895%
2/13/2025	Invesco Ltd.	508,069	$18.37M	0.0%	+4.5%	0.920%
2/13/2025	Bank of Montreal Can	7,595	$0.28M	0.0%	+6.6%	0.014%
2/13/2025	Federated Hermes Inc.	1,606	$58K	0.0%	-96.2%	0.003%
2/13/2025	Russell Investments Group Ltd.	96,395	$3.49M	0.0%	-12.0%	0.175%
2/13/2025	Envestnet Asset Management Inc.	59,970	$2.17M	0.0%	+6.2%	0.109%
2/13/2025	Wells Fargo & Company MN	63,237	$2.29M	0.0%	+14.4%	0.115%
2/12/2025	Villanova Investment Management Co LLC	57,032	$2.06M	1.8%	+10.7%	0.103%
2/12/2025	Trexquant Investment LP	74,275	$2.69M	0.0%	-21.8%	0.135%
2/12/2025	Headlands Technologies LLC	1,515	$55K	0.0%	+203.0%	0.003%
2/12/2025	Geode Capital Management LLC	1,510,568	$54.63M	0.0%	+1.9%	2.736%
2/12/2025	Franklin Resources Inc.	31,608	$1.14M	0.0%	+5.4%	0.057%
2/12/2025	Axiom Investors LLC DE	69,896	$2.53M	0.0%	+38.9%	0.127%
2/12/2025	Wellington Management Group LLP	23,500	$0.85M	0.0%	-10.7%	0.043%
2/12/2025	Schroder Investment Management Group	298,657	$11.02M	0.0%	-42.0%	0.541%
2/12/2025	Arrowstreet Capital Limited Partnership	174,916	$6.33M	0.0%	+79.4%	0.317%
2/12/2025	Pictet Asset Management Holding SA	526,252	$19.03M	0.0%	-6.1%	0.953%
2/12/2025	Norges Bank	125,551	$4.54M	0.0%	N/A	0.227%
2/12/2025	Loomis Sayles & Co. L P	1,467,027	$53.05M	5.7%	-3.2%	2.657%
2/12/2025	JPMorgan Chase & Co.	297,810	$10.77M	0.0%	+17.5%	0.539%
2/12/2025	Mark Sheptoff Financial Planning LLC	1,450	$52K	0.0%	N/A	0.003%
2/11/2025	Prudential Financial Inc.	66,733	$2.37M	0.0%	+14.3%	0.121%
2/11/2025	Corebridge Financial Inc.	26,913	$0.97M	0.0%	-7.2%	0.049%
2/11/2025	Vanguard Group Inc.	6,150,759	$222.41M	0.0%	+0.4%	11.139%
2/11/2025	Bridge City Capital LLC	94,997	$3.44M	0.9%	+0.8%	0.172%
2/11/2025	LPL Financial LLC	12,741	$0.46M	0.0%	+18.9%	0.023%
2/11/2025	Fox Run Management L.L.C.	35,900	$1.30M	0.2%	N/A	0.065%
2/11/2025	KLP Kapitalforvaltning AS	41,700	$1.51M	0.0%	N/A	0.076%
2/11/2025	Sei Investments Co.	296,915	$10.74M	0.0%	-5.4%	0.538%
2/11/2025	American Century Companies Inc.	1,140,705	$41.25M	0.0%	+9.2%	2.066%
2/11/2025	Teacher Retirement System of Texas	16,331	$0.59M	0.0%	+18.5%	0.030%
2/10/2025	Thrivent Financial for Lutherans	42,682	$1.54M	0.0%	-1.4%	0.077%
2/10/2025	Retirement Planning Co of New England Inc.	21,427	$0.78M	0.4%	-4.5%	0.039%
2/10/2025	Royce & Associates LP	12,938	$0.47M	0.0%	N/A	0.023%

Data available starting January 2016

See Full Table

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. The company's commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset seizures in adults and children between 6 to 17 years of age. It also offers comprise Qelbree, a novel non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, the company's product candidates include SPN-830, a late-stage drug/device combination product candidate for the treatment of off episodes in PD patients; SPN-817, a novel first-in-class selective acetylcholinesterase inhibitor, which is in Phase II clinical trials for the treatment of epilepsy; SPN-820, a product candidate in Phase II clinical trials for treating resistant depression; SPN-443, a preclinical product for the treatment of ADHD/CNS; and SPN-446 for narcolepsy and SPN-448 for the treatment of CNS which is in discovery stage. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Rockville, Maryland.

Today's Range

Now: $32.16

$30.94

$32.35

50 Day Range

MA: $36.13

$31.17

$40.00

52 Week Range

Now: $32.16

$25.53

$40.28

Volume

417,883 shs

Average Volume

462,716 shs

Market Capitalization

$1.79 billion

P/E Ratio

30.06

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of Supernus Pharmaceuticals?: Supernus Pharmaceuticals' top insider investors include:
Jack A Khattar (CEO)
Tami Tillotson Martin (VP)
Frederick M Hudson (Director)
Georges Gemayel (Director)
Padmanabh P Bhatt (VP)
Frank Mottola (SVP)
Jonathan Rubin (SVP)
Learn More about top insider investors at Supernus Pharmaceuticals.
Who are the major institutional investors of Supernus Pharmaceuticals?: Supernus Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 11.14%
Dimensional Fund Advisors LP — 5.21%
Stephens Investment Management Group LLC — 3.17%
Polar Capital Holdings Plc — 3.06%
Renaissance Technologies LLC — 2.90%
Pacer Advisors Inc. — 2.89%
Learn More about top institutional investors of Supernus Pharmaceuticals stock.
Which major investors are selling Supernus Pharmaceuticals stock?: In the last quarter, SUPN stock was sold by these institutional investors:
Polar Capital Holdings Plc
Millennium Management LLC
Schroder Investment Management Group
Stephens Investment Management Group LLC
Pacer Advisors Inc.
Renaissance Technologies LLC
Aristotle Capital Boston LLC
Voloridge Investment Management LLC
Within the last year, company insiders that have sold Supernus Pharmaceuticals company stock include:
Jack A Khattar (CEO)
Tami Tillotson Martin (VP)
Frederick M Hudson (Director)
Georges Gemayel (Director)
Padmanabh P Bhatt (VP)
Learn More investors selling Supernus Pharmaceuticals stock.
Which major investors are buying Supernus Pharmaceuticals stock?: In the last quarter, SUPN stock was bought by institutional investors including:
Woodline Partners LP
BNP Paribas Financial Markets
Raymond James Financial Inc.
Raymond James Financial Inc.
Great Lakes Advisors LLC
D. E. Shaw & Co. Inc.
Cubist Systematic Strategies LLC
Norges Bank